Completed

Research of Prognostic Factors Associated With Healing of Venous Leg Ulcers

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Psychological tests

Other
Who is being recruted

Skin Diseases+1

+ Skin Ulcer

+ Skin and Connective Tissue Diseases

Over 50 Years
+13 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Other Study

Interventional
Study Start: January 2003
See protocol details

Summary

Principal SponsorCentre Hospitalier Universitaire, Amiens
Last updated: September 22, 2025
Sourced from a government-validated database.Claim as a partner

Study start date: January 1, 2003

Actual date on which the first participant was enrolled.

This study was undertaken to identify prospectively which clinical venous leg ulcer (VLU) characteristics known as possible prognostic markers, and which sociodemographic and psychologic factors associated with VLU are associated with complete healing at 24 weeks.

NCT01673412
Principal SponsorCentre Hospitalier Universitaire, Amiens
Last updated: September 22, 2025
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

104 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Other Study

Some studies explore topics that don't fall into a specific category. These might include innovative research, new technologies, or emerging healthcare areas.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 50 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Skin DiseasesSkin UlcerSkin and Connective Tissue DiseasesLeg Ulcer

Criteria

8 inclusion criteria required to participate
ability to be followed for 24 weeks
ability to give informed consent
absence of significant arterial insufficiency assessed by clinical findings (intermittent claudication or resting pain, necrotic or distal foot wound) and by an ankle brachial index (ABI) >= 0.8
ambulatory or hospitalized patients
Show More Criteria
5 exclusion criteria prevent from participating
ABI < 0.8
corticosteroid, cytotoxic or immunosuppressant drug use during the preceding 3 months
foot ulcer
hypertensive leg ulcer
Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Psychological tests

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 35 locations

Centre Hospitalo-Universitaire d'Amiens - Dermatologie

Amiens, FranceOpen Centre Hospitalo-Universitaire d'Amiens - Dermatologie in Google Maps

Hôpital Saint Vincent de Paul - Médecine interne et Gériatrie I

Amiens, France

Hôpital Victor Dupouy - Dermatologie

Argenteuil, France

Hôpital Saint Jacques - Dermatologie 1

Besançon, France
Completed35 Study Centers